LAMEA Omega 3 Supplements Market Size, Share & Trends Analysis Report By Functionality, By End Use, By Source, By Distribution Channel, By Form, By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa Omega 3 Supplements Market is expected to witness market growth of 10.8% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Omega 3 Supplements Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $315.3 million by 2031. The Argentina market is showcasing a CAGR of 11.5% during 2024-2031. Additionally, the UAE market would register a CAGR of 9.7% during 2024-2031.



The applications of omega-3 supplements are vast and multifaceted, reflecting their versatility in addressing a wide array of health needs. The most prominent application lies in dietary supplements, where omega-3s are consumed to meet daily nutritional requirements and support overall health. These supplements are particularly popular for their cardiovascular benefits, as EPA and DHA have been linked to reduced triglyceride levels, lower blood pressure, and a decreased risk of heart disease - a critical concern given that cardiovascular issues remain a leading cause of mortality globally. In the United States, for instance, coronary heart disease accounts for a significant portion of deaths, amplifying the demand for omega-3 supplements as a preventive measure.

Moreover, beyond cardiovascular health, omega-3 supplements are widely applied in cognitive and neurological support. DHA, a key component of brain tissue, is essential for infant brain development and cognitive function in adults. This has led to their incorporation into infant formulas, ensuring that young children receive adequate levels for optimal growth. For aging populations, omega-3s are marketed as a tool to combat cognitive decline, with potential benefits for conditions like dementia and Alzheimer’s disease. As per the WHO, more than 55 million people have dementia worldwide, over 60% of whom live in low-and middle-income countries. Every year, there are nearly 10 million new cases.

Saudi Arabia’s pharmaceutical industry is expected to grow 7.3% from 2020 to 2027, mainly due to the increasing number of drug approvals and new product launches. This growth directly impacts the market, as Omega-3 fatty acids are widely used in pharmaceutical formulations for cardiovascular health, brain function, and inflammation reduction. With rising cases of heart disease and lifestyle-related illnesses in Saudi Arabia, demand for Omega-3 supplements is increasing as a preventive healthcare solution. Additionally, government support for pharmaceutical expansion enhances the availability and acceptance of Omega-3-based drugs and supplements.

List of Key Companies Profiled

• Nordic Naturals, Inc.
• Nutrigold Inc.
• Reckitt Benckiser Group PLC
• Aker BioMarine AS
• NOW Foods, Inc.
• Nature's Bounty (Nestlé Health Science S.A.) (Nestle S.A.)
• Amway Corporation
• New Chapter, Inc. (Procter & Gamble Inc.)
• GNC Holdings, LLC
• Pharmavite LLC (Otsuka Pharmaceutical Co., Ltd.)

Market Report Segmentation

By Functionality

• Cardiovascular Health
• Brain, Nervous System & Mental Health
• Eye Diseases
• Diabetes
• Other Functionality

By End Use

• Adults
• Geriatric
• Pregnant Women
• Children
• Infants

By Source

• Fish Oil
• Algae Oil
• Krill Oil
• Other Source

By Distribution Channel

• Supermarkets/ Hypermarkets/Food Stores
• Drug Stores & Pharmacies
• Online Retailers
• Prescribed
• Other Distribution Channel

By Form

• Soft Gels
• Capsules
• Tablets
• Other Form

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA